Assignee
MITOCHON PHARMACEUTICALS INC
US·6 granted patents·2 pending applications·16 citations·filing 2016–2023
Top patents by PatentIndex Score
8 records- 0190US9974755B2Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseasesMITOCHON PHARMACEUTICALS INC·Filed 2016·Granted May 22, 2018·9 cites·21 claims
- 0288US10864173B2Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseasesMITOCHON PHARMACEUTICALS INC·Filed 2019·Granted Dec 15, 2020·2 cites·19 claims
- 0386US10220006B2Induced expression of brain derived neurotrophic factor (BDNF) for treatment of Neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseasesMITOCHON PHARMACEUTICALS INC·Filed 2017·Granted Mar 5, 2019·4 cites·26 claims
- 0483US2024156750A1Induced Expression of Brain Derived Neurotrophic Factor (BDNF) for Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental and/or Metabolic DiseasesMITOCHON PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0573US11717497B2Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseasesMITOCHON PHARMACEUTICALS INC·Filed 2020·Granted Aug 8, 2023·0 cites·23 claims
- 0672US10548900B2DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseasesMITOCHON PHARMACEUTICALS INC·Filed 2017·Granted Feb 4, 2020·1 cites·21 claims
- 0770US2023100940A1DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic DiseasesMITOCHON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0864US11406642B2DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseasesMITOCHON PHARMACEUTICALS INC·Filed 2019·Granted Aug 9, 2022·0 cites·16 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →